Lixiang Xue | Cancer | Best Researcher Award

Prof. Lixiang Xue | Cancer | Best Researcher Award

Prof. Lixiang Xue | Cancer | Director at Peking University Third Hospital | China

Prof. Xue Lixiang is a distinguished scholar in the field of biomedical sciences, recognized for his pioneering contributions to cancer biology, immunology, and molecular medicine. His research has significantly advanced the understanding of how molecular mechanisms such as microRNAs, chromatin dynamics, and immune modulation influence cancer development, progression, and treatment response. With a strong background in translational research, he has integrated experimental biology with clinical applications, aiming to create innovative solutions for some of the most pressing medical challenges. His scholarship is evidenced by extensive publications in high-impact journals, citations that reflect wide recognition of his work, and consistent involvement in collaborative projects that bridge basic science and clinical practice.

Academic Profile:

ORCID

Google Scholar

Education:

Prof. Xue Lixiang completed his doctoral studies in biomedical sciences with a concentration on molecular and cellular biology. His academic journey has been marked by rigorous training in epigenetics, cancer biology, and immunotherapy. During his education, he cultivated a multidisciplinary foundation, drawing on molecular biology, bioinformatics, and translational medicine. His strong academic record and advanced research training have enabled him to contribute to complex investigations that require both theoretical depth and practical application. His education provided the platform from which he has launched a career dedicated to innovative and impactful scientific contributions.

Experience:

Prof. Xue Lixiang has built a career of remarkable breadth and depth, holding academic and research roles that have allowed him to influence both scholarship and practice. His professional experience spans laboratory research, international collaborations, and leadership in research projects addressing cancer diagnostics, immunological therapies, and chronic disease management. He has contributed extensively to peer-reviewed literature, with his work indexed in leading databases such as Scopus and Web of Science. In addition, he has taken part in editorial duties, peer-review processes, and the mentorship of emerging scientists, strengthening academic communities and promoting high-quality research standards. Through his extensive experience, he has become a central figure in advancing the global dialogue on cancer biology and translational medicine.

Research Interest:

The research interests of Prof. Xue Lixiang encompass cancer biology, immunology, epigenetics, and molecular therapeutics. He has devoted substantial effort to exploring the regulatory functions of microRNAs in cancer progression and therapy, highlighting their potential as biomarkers and therapeutic targets. His work on tumor-associated macrophages, cellular senescence, and immune cell modulation has shed light on new therapeutic strategies for oncology. Additionally, he has contributed to understanding the role of gut microbiota in cardiovascular and metabolic diseases, illustrating his ability to bridge oncology with broader health issues. His research demonstrates a consistent commitment to addressing complex biomedical challenges by integrating molecular discoveries with clinical potential, advancing both scientific knowledge and patient care.

Award:

Prof. Xue Lixiang has been recognized for his significant contributions through various research awards and academic honors. These recognitions reflect the high regard in which his peers and the broader scientific community hold his work. His achievements have been acknowledged not only through citations and journal publications but also through invitations to participate in international collaborations, research panels, and academic forums. Such recognition is a testament to the impact and relevance of his contributions in shaping the future of biomedical sciences.

Selected Publications:

  • Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage (2018) – Citations: 564

  • Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation (2012) – Citations: 330

  • Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer (2021) – Citations: 293

  • MicroRNA-31 reduces inflammatory signaling and promotes regeneration in colon epithelium (2019) – Citations: 210

Conclusion:

In conclusion, Prof. Xue Lixiang is a visionary researcher whose scholarship has reshaped understanding in cancer biology, immunology, and epigenetics. His academic training, professional experience, and internationally recognized publications establish him as a leading authority in his field. Through sustained research excellence, he has advanced the development of innovative therapeutic approaches and opened new pathways for clinical application. The recognition of his work through citations, awards, and collaborations underscores his influence in both academic and clinical communities. Prof. Xue Lixiang is highly deserving of this award nomination, not only for his past achievements but also for his potential to drive future advancements in biomedical research and global health.

 

 

Prof. Dr. Huda AlMohammed | Radiotherapy | Best Researcher Award

Prof. Dr. Huda AlMohammed | Radiotherapy | Best Researcher Award

Prof. Dr. Huda AlMohammed | Radiotherapy – Professor at Princess Nourah Bint Abdulrahman University, Saudi Arabia

Prof. Huda Almohammed is a distinguished academic and research expert in the field of Medical Physics and Radiation Therapy, known for her impactful contributions to radiation protection, oncology applications, and interdisciplinary advancements in health sciences. She is widely recognized for bridging clinical medical physics with applied research to improve patient outcomes and reduce radiological risks. Her scholarly record is marked by consistent publication in peer-reviewed journals and active collaboration with leading scientists in radiological sciences. Her innovative approach, dedication to academic integrity, and focus on high-impact healthcare challenges place her among the prominent researchers advancing medical physics in the 21st century.

Profile Verified:

Scopus | Google Scholar

Education:

Prof. Almohammed’s educational foundation is rooted in radiation sciences, medical physics, and therapeutic applications. She has undergone rigorous academic training and professional development that has equipped her with expertise in diagnostic imaging, radiation dosimetry, nuclear medicine, and oncology physics. Through postgraduate specialization and continuous academic certifications, she has built a robust knowledge base that supports her leadership in both clinical and research environments. Her educational journey has been marked by both depth and interdisciplinary integration, enabling her to operate at the confluence of theory, application, and policy.

Experience:

Over the years, Prof. Almohammed has held significant academic and research roles in medical institutions, where she has contributed to curriculum design, radiation safety training, and the supervision of postgraduate research. She has worked collaboratively with esteemed institutions and professionals in Saudi Arabia, Malaysia, and Europe, demonstrating global competence. Her experience encompasses applied nuclear science, radiological assessments, radiation oncology procedures, and occupational risk evaluations. In clinical settings, she has participated in optimizing imaging protocols and implementing safe radiological practices. Her academic presence is further strengthened by conference presentations, workshops, and peer-review activities.

Research Interest:

Prof. Almohammed’s research interests center around radiation dose optimization, biological risk assessment in imaging and therapy, radiation safety protocols, and the application of artificial intelligence in diagnostic radiology. A core focus of her work involves evaluating patient and staff exposure in nuclear medicine and interventional radiology procedures, with the goal of minimizing risks and ensuring safety in clinical environments. Additionally, she is interested in the integration of machine learning models to predict and explain health risks, especially in oncology. Her interdisciplinary work spans education technology, radiological awareness, and digital transformation in medical training during public health emergencies.

Award:

Prof. Almohammed’s research achievements and contributions to radiation protection and patient safety in medical physics make her a strong contender for the Best Researcher Award. Her impact spans both scientific advancement and practical application, with notable involvement in AI-driven studies and risk assessment frameworks. Through multi-institutional collaborations and publication in international journals, she has demonstrated sustained academic excellence, leadership, and relevance to pressing healthcare issues. Her scholarship supports improved clinical standards and contributes directly to safer imaging and therapeutic practices, aligning well with the mission of honoring researchers with outstanding global contributions.

Publication:

  • Exploring the relationship between students’ learning satisfaction and self-efficacy during the emergency transition to remote learning amid the coronavirus pandemic: A cross … (2022, Education and Information Technologies) – cited by 147
  • Patient radiation biological risk in computed tomography angiography procedure (2017, Saudi Journal of Biological Sciences) – cited by 79
  • Anticancer activity of EA1 extracted from Equisetum arvense (2017, Pak. J. Pharm. Sci) – cited by 33
  • Assessment of occupational exposure and radiation risks in nuclear medicine departments (2020, Radiation Physics and Chemistry) – cited by 31
  • Estimation of cancer risks during mammography procedure in Saudi Arabia (2019, Saudi Journal of Biological Sciences) – cited by 25
  • The efficacy of machine learning models in lung cancer risk prediction with explainability (2024, PLOS ONE) – cited by 8
  • Artificial intelligence-based fuzzy logic systems for predicting radiation protection awareness levels among university population (2023, Radiation Physics and Chemistry) – cited by 6

Conclusion:

In summary, Prof. Huda Almohammed exemplifies the qualities of a dedicated and high-impact researcher in the domain of medical physics and radiation therapy. Her work addresses critical issues in radiation exposure, patient safety, and technological innovation in health sciences. With a consistent track record of research excellence, academic leadership, and multidisciplinary collaboration, she has significantly influenced both theoretical frameworks and clinical practices. Her evolving interests in AI applications and educational technology further demonstrate her forward-thinking approach. Prof. Almohammed’s achievements and continued commitment to research innovation make her an outstanding nominee for the Best Researcher Award, and her contributions stand to inspire future developments in global health and medical physics.